Emulate and AstraZeneca Form Strategic Agreement to Work Side-by-Side on Organs-on-Chips Technology Read more
UCB announces BRIVIACT (brivaracetam) now approved by FDA to treat partial-onset (focal) seizures in pediatric epilepsy patients Read more
Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies Read more